Clinical judgment reviewed years later by someone reading only the chart.
Hospice and home health sit among the most heavily audited corners of Medicare, reviewed by UPICs, RACs, the SMRC, and MAC targeted probe and educate. The recurring theme is that eligibility decisions made clinically at the bedside are re-examined much later against the documentation alone.
For hospice that means terminal prognosis, certification and recertification, the face-to-face encounter, and the plan of care. For home health it means homebound status, the face-to-face encounter and its documentation, medical necessity, and physician orders. Where a sample is extrapolated, a handful of disputed charts becomes a demand across the whole population.
.png)
Three exposures that decide the size of a hospice or home health audit.
Reviewers examine a sample, calculate an error rate, and project it across the universe of claims. The projection, not the individual charts, is what produces demands that dwarf the value of the claims actually reviewed. Challenging the sampling methodology and the statistics is a distinct line of defense from arguing the clinical merits.
A physician's prognosis or homebound determination is reasonable at the time and reviewed later by someone with only the chart. Documentation that reflected sound clinical judgment but recorded it thinly is where most denials live, and it is largely fixable prospectively.
Payment suspension, prepayment review, and revocation of billing privileges can be imposed while a matter is unresolved. For agencies with payroll running against Medicare receipts, the interim measure is frequently more dangerous than the eventual overpayment finding.
Four features that shape hospice and home health audit defense.
Clinical review and statistical challenge run in parallel.
We calendar every deadline, assess the scope of the request, and address any payment suspension or prepayment review immediately, because the interim cash position often matters more than the eventual number.
Clinician and lawyer review each disputed chart against the actual coverage criteria, separating genuine eligibility problems from documentation and procedural denials, which are usually the larger share.
Where a demand is extrapolated we examine the sampling frame, sample size, methodology, and statistical validity. A successful challenge to the projection can reduce a demand by far more than winning individual charts.
We take the strongest issues through the appeal levels and, in parallel, correct the documentation practices that produced the denials, so the next review looks different from this one.
Anthony's background as a former federal prosecutor and executive for major healthcare companies provided a level of expertise and insight that made all the difference. His deep understanding of healthcare law, particularly in litigation and compliance matters, helped navigate complex legal issues with ease.
Send us the audit letter and the sampled claims. We will tell you which denials are defensible, whether the extrapolation is vulnerable, and what to do about any payment suspension. Free, confidential, no retainer.
